Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Meningeal lymphatics prime tumor immunity in glioblastoma.

Literature DB >> 33689701

Meningeal lymphatics prime tumor immunity in glioblastoma.

Abstract

The notion of the brain as an immune-privileged organ has been challenged by the discovery of functional lymphatic vessels in the meninges of the dorsal and basal skull. A study published in Nature in 2020 shows that meningeal lymphatics play an important role in the sensing of brain tumor antigens.

Entities: Chemical

Mesh：

Year: 2021 PMID： 33689701 PMCID： PMC9549925 DOI： 10.1016/j.ccell.2021.02.012

Source DB: PubMed Journal: Cancer Cell ISSN： 1535-6108 Impact factor: 38.585

10 in total

1. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Authors: Qianghu Wang; Baoli Hu; Xin Hu; Hoon Kim; Massimo Squatrito; Lisa Scarpace; Ana C deCarvalho; Sali Lyu; Pengping Li; Yan Li; Floris Barthel; Hee Jin Cho; Yu-Hsi Lin; Nikunj Satani; Emmanuel Martinez-Ledesma; Siyuan Zheng; Edward Chang; Charles-Etienne Gabriel Sauvé; Adriana Olar; Zheng D Lan; Gaetano Finocchiaro; Joanna J Phillips; Mitchel S Berger; Konrad R Gabrusiewicz; Guocan Wang; Eskil Eskilsson; Jian Hu; Tom Mikkelsen; Ronald A DePinho; Florian Muller; Amy B Heimberger; Erik P Sulman; Do-Hyun Nam; Roel G W Verhaak
Journal: Cancer Cell Date: 2018-01-08 Impact factor: 31.743

Review 2. Oncology meets immunology: the cancer-immunity cycle.

Authors: Daniel S Chen; Ira Mellman
Journal: Immunity Date: 2013-07-25 Impact factor: 31.745

Review 3. Current state of immunotherapy for glioblastoma.

Authors: Michael Lim; Yuanxuan Xia; Chetan Bettegowda; Michael Weller
Journal: Nat Rev Clin Oncol Date: 2018-07 Impact factor: 66.675

4. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.

Authors: Timothy F Cloughesy; Aaron Y Mochizuki; Joey R Orpilla; Willy Hugo; Alexander H Lee; Tom B Davidson; Anthony C Wang; Benjamin M Ellingson; Julie A Rytlewski; Catherine M Sanders; Eric S Kawaguchi; Lin Du; Gang Li; William H Yong; Sarah C Gaffey; Adam L Cohen; Ingo K Mellinghoff; Eudocia Q Lee; David A Reardon; Barbara J O'Brien; Nicholas A Butowski; Phioanh L Nghiemphu; Jennifer L Clarke; Isabel C Arrillaga-Romany; Howard Colman; Thomas J Kaley; John F de Groot; Linda M Liau; Patrick Y Wen; Robert M Prins
Journal: Nat Med Date: 2019-02-11 Impact factor: 53.440

5. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.

Authors: Katrin Aslan; Verena Turco; Jens Blobner; Jana K Sonner; Anna Rita Liuzzi; Nicolás Gonzalo Núñez; Donatella De Feo; Philipp Kickingereder; Manuel Fischer; Ed Green; Ahmed Sadik; Mirco Friedrich; Khwab Sanghvi; Michael Kilian; Frederik Cichon; Lara Wolf; Kristine Jähne; Anna von Landenberg; Lukas Bunse; Felix Sahm; Daniel Schrimpf; Jochen Meyer; Allen Alexander; Gianluca Brugnara; Ralph Röth; Kira Pfleiderer; Beate Niesler; Andreas von Deimling; Christiane Opitz; Michael O Breckwoldt; Sabine Heiland; Martin Bendszus; Wolfgang Wick; Burkhard Becher; Michael Platten
Journal: Nat Commun Date: 2020-02-18 Impact factor: 14.919

Review 6. Afferent Lymphatic Transport and Peripheral Tissue Immunity.

Authors: Maria M Steele; Amanda W Lund
Journal: J Immunol Date: 2021-01-15 Impact factor: 5.422

7. VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance.

Authors: Signe R Michaelsen; Mikkel Staberg; Henriette Pedersen; Kamilla E Jensen; Wiktor Majewski; Helle Broholm; Mette K Nedergaard; Christopher Meulengracht; Thomas Urup; Mette Villingshøj; Slávka Lukacova; Jane Skjøth-Rasmussen; Jannick Brennum; Andreas Kjær; Ulrik Lassen; Marie-Thérése Stockhausen; Hans S Poulsen; Petra Hamerlik
Journal: Neuro Oncol Date: 2018-10-09 Impact factor: 12.300

8. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature.

Authors: Antoine Louveau; Jasmin Herz; Maria Nordheim Alme; Andrea Francesca Salvador; Michael Q Dong; Kenneth E Viar; S Grace Herod; James Knopp; Joshua C Setliff; Alexander L Lupi; Sandro Da Mesquita; Elizabeth L Frost; Alban Gaultier; Tajie H Harris; Rui Cao; Song Hu; John R Lukens; Igor Smirnov; Christopher C Overall; Guillermo Oliver; Jonathan Kipnis
Journal: Nat Neurosci Date: 2018-09-17 Impact factor: 24.884

9. Meningeal lymphatic vessels regulate brain tumor drainage and immunity.

Authors: Xueting Hu; Qiuping Deng; Lu Ma; Qingqing Li; Yidong Chen; Yuhan Liao; Fan Zhou; Chen Zhang; Linlin Shao; Jun Feng; Tubao He; Weihai Ning; Yan Kong; Yingqing Huo; Aibin He; Bing Liu; Jingjing Zhang; Ralf Adams; Yulong He; Fuchou Tang; Xiuwu Bian; Jincai Luo
Journal: Cell Res Date: 2020-02-24 Impact factor: 25.617

10. VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours.

Authors: Eric Song; Tianyang Mao; Huiping Dong; Ligia Simoes Braga Boisserand; Salli Antila; Marcus Bosenberg; Kari Alitalo; Jean-Leon Thomas; Akiko Iwasaki
Journal: Nature Date: 2020-01-15 Impact factor: 49.962